Novel approaches to global mining of aberrantly methylated promoter sites in squamous head and neck cancer
- 31 July 2010
- journal article
- Published by Wiley in Otolaryngology -- Head and Neck Surgery
- Vol. 143 (1), 116-21, 121.e1
- https://doi.org/10.1016/j.otohns.2010.02.015
Abstract
Objective: Promoter hypermethylation is emerging as a promising molecular strategy for early detection of cancer. We examined promoter methylation status of 1143 cancer-associated genes to perform a global but unbiased inspection of methylated regions in head and neck squamous cell carcinoma (HNSCC). Study Design: Laboratory-based study. Setting: Integrated health care system. Subjects and Methods: Five samples, two frozen primary HNSCC biopsies and three HNSCC cell lines, were examined. Whole genomic DNA was interrogated using a combination of DNA immunoprecipitation (IP) and Affymetrix whole-genome tiling arrays. Results: Of the 1143 unique cancer genes on the array, 265 were recorded across five samples. Of the 265 genes, 55 were present in all five samples, and 36 were common to four of five samples, 46 to three of five, 56 to two of five, and 72 to one of five samples. Hypermethylated genes in the five samples were cross-examined against those in PubMeth, a cancer methylation database combining text mining and expert annotation (http://www.pubmeth.org). Of the 441 genes in PubMeth, only 33 are referenced to HNSCC. We matched 34 genes in our samples to the 441 genes in the PubMeth database. Of the 34 genes, eight are reported in PubMeth as HNSCC associated. Conclusion: This pilot study examined the contribution of global DNA hypermethylation to the pathogenesis of HNSCC. The whole-genome methylation approach indicated 231 new genes with methylated promoter regions not yet reported in HNSCC. Examination of this comprehensive gene panel in a larger HNSCC cohort should advance selection of HNSCC-specific candidate genes for further validation as biomarkers in HNSCC.Keywords
This publication has 23 references indexed in Scilit:
- Differential Methylation Status of Tumor-Associated Genes in Head and Neck Squamous CarcinomaClinical Cancer Research, 2004
- Detection of Promoter Hypermethylation of Tumor Suppressor Genes in Urine from Kidney Cancer PatientsAnnals of the New York Academy of Sciences, 2004
- Delineating Genetic Pathways of Disease Progression in Head and Neck Squamous Cell CarcinomaJAMA Otolaryngology–Head & Neck Surgery, 2003
- Differential targets of CpG island hypermethylation in primary and metastatic head and neck squamous cell carcinoma (HNSCC)Journal of Medical Genetics, 2003
- Methylation mattersJournal of Medical Genetics, 2001
- A gene hypermethylation profile of human cancer.2001
- Facile Detection of Mitochondrial DNA Mutations in Tumors and Bodily FluidsScience, 2000
- Gene promoter hypermethylation in tumors and serum of head and neck cancer patients.2000
- Aberrant CpG-island methylation has non-random and tumour-type–specific patternsNature Genetics, 2000
- Mammalian O6-alkylguanine-DNA alkyltransferase: regulation and importance in response to alkylating carcinogenic and therapeutic agents.1990